Expert panel asks drug cos to submit subgroup data on Molnupiravir

Molnupiravir is the first oral antiviral approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment of mild-to-moderate Covid-19 in adults.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3CyhZEa
via IFTTT